Atlas Trials

A Study to Learn How the Study Treatment BAY3283142 Taken as Single Dose by Mouth Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function of Similar Age, Gender, and Weight

Clinical trial NCT05515432 · COMPLETED

Trial details

NCT number
NCT05515432
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Kidney DiseaseRenal ImpairmentHealthy Volunteers
Start date
2022-08-11
Primary completion
2023-03-07
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.